PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.

Cytology and Genetics is an esteemed academic journal published by PLEIADES PUBLISHING INC, dedicated to advancing research within the fields of cytology, cellular biology, and genetics. Since its inception in 1978, the journal has served as a platform for disseminating innovative findings and methodologies pertinent to contemporary biological sciences. With an ISSN of 0095-4527 and an E-ISSN of 1934-9440, Cytology and Genetics offers critical insights that significantly contribute to the current understanding of genetic mechanisms and cellular processes. Despite its present positioning in the Q4 quartile across multiple categories, including Agricultural and Biological Sciences and Cell Biology, the journal remains a crucial resource for emerging researchers seeking to explore complex genetic and cytogenetic landscapes. With an emphasis on empirical studies and comprehensive reviews, the journal aims to bridge gaps in knowledge and foster collaboration among scholars in the United States and beyond. As a vital tool for students, professionals, and researchers, Cytology and Genetics invites contributions that reflect the future of genetics and cytological science.

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.

ACTA CYTOLOGICA is a premier journal dedicated to the field of cytology, offering a platform for researchers, professionals, and students interested in the intricate study of cellular biology and its applications in the medical domain. Published by KARGER in Switzerland, the journal has been a vital resource since its inception in 1960 and is recognized for its rigorous peer-reviewed articles. With a notable impact factor reflecting its significance—ranked in the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, and Q3 in Histology for 2023—ACTA CYTOLOGICA continues to contribute valuable insights into cytological research and its implications for clinical practice. The journal maintains an annual focus on cutting-edge studies and reviews that enhance understanding and methodological advancements in cytology. Although it does not provide open access, it remains an essential read for those involved in histology and pathology, promising to keep them abreast of the latest findings and technological innovations in the field.

CytoJournal is a leading open-access journal focused on the fields of pathology and forensic medicine, published by SCIENTIFIC SCHOLAR LLC. With its esteemed reputation, the journal has achieved a Q2 ranking in the 2023 Category Quartiles in its field, indicating its significant contribution and impact among its peers. Over its convergence from 2004 to 2024, CytoJournal has established itself as a pivotal platform for researchers, professionals, and students to disseminate and exchange pioneering research findings related to cytopathology and diagnostic techniques. With an emerging Scopus rank of #115 out of 208 in the field, the journal maintains a solid percentile ranking of 44th, underlining its importance in the scientific community. CytoJournal's commitment to facilitating open access ensures that critical insights and advancements in pathology and forensic medicine are easily accessible to those at the forefront of this essential area of study.

DIAGNOSTIC CYTOPATHOLOGY is a scholarly journal dedicated to advancing the field of cytopathology through the publication of high-quality research and reviews. Founded in 1985 and published by Wiley, this journal provides vital insights into the diagnosis and management of diseases through cytological techniques. With a strong presence in the academic community, it currently holds a Q3 ranking in the fields of Histology, Medicine (miscellaneous), and Pathology and Forensic Medicine, reflecting its commitment to fostering knowledge and innovation in these areas. Researchers and clinicians alike can benefit from its comprehensive articles that delve into cutting-edge methodologies and diagnostic strategies. Although not an Open Access journal, DIAGNOSTIC CYTOPATHOLOGY remains a crucial resource for professionals seeking to enhance their understanding and practice in the diagnostic realm. With an ISSN of 8755-1039 and an E-ISSN of 1097-0339, the journal continues to publish impactful studies well into 2024, ensuring that essential advancements in cytopathology reach a global audience.

Diagnostic and Interventional Imaging, published by Elsevier Masson, stands as a prominent journal in the fields of Radiology, Nuclear Medicine, and Imaging. With a significant impact factor and a reputation for high-quality research, this journal is dedicated to advancing the understanding and application of diagnostic and interventional imaging techniques. It has achieved an impressive Q1 ranking across multiple categories including Medicine (miscellaneous) and Radiological and Ultrasound Technology, demonstrating its esteemed position within the academic community. The journal features cutting-edge studies and reviews, reflecting the latest innovations and practices from 2012 to 2024. Researchers, healthcare professionals, and students alike can look forward to accessing valuable insights that drive forward the discipline and improve patient outcomes, as evidenced by its robust Scopus rankings placing it among the top journals in its domain.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.